We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

146 hedge funds and large institutions have $897M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

29% more call options, than puts

Call options by funds: $576K | Put options by funds: $446K

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

7% more capital invested

Capital invested by funds: $839M → $897M (+$57.7M)

2% more funds holding

Funds holding: 143 → 146 (+3)

Holders
146
Holders Change
+3
Holders Change %
+2.1%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
25
Increased
59
Reduced
41
Closed
22
Calls
$576K
Puts
$446K
Net Calls
+$130K
Net Calls Change
-$4.48M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$47.9M
2
RG
Redmile Group
California
+$33.2M
3
DTC
Deep Track Capital
Connecticut
+$22.8M
4
JFG
Jefferies Financial Group
New York
+$16.7M
5
Goldman Sachs
Goldman Sachs
New York
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
Wolverine Trading
Wolverine Trading
Illinois
-$28.7M
2
APM
Avidity Partners Management
Texas
-$18.5M
3
AC
Armistice Capital
New York
-$17.9M
4
Millennium Management
Millennium Management
New York
-$6.71M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$5.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$6.43M +$6.35M +380,355 +1,058%
WP
27
Woodline Partners
California
$5.25M +$5.68M +339,905 New
Bank of America
28
Bank of America
North Carolina
$5.16M +$831K +49,781 +18%
Norges Bank
29
Norges Bank
Norway
$4.44M +$4.79M +287,068 New
HIM
30
Hillsdale Investment Management
Ontario, Canada
$3.91M -$1.25M -75,000 -23%
SSA
31
Schonfeld Strategic Advisors
New York
$3.82M +$893K +53,472 +28%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$3.62M -$311K -18,611 -7%
Renaissance Technologies
33
Renaissance Technologies
New York
$3.57M +$2.35M +140,618 +155%
Public Sector Pension Investment Board (PSP Investments)
34
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.31M – – –
Citigroup
35
Citigroup
New York
$2.96M +$1.33M +79,398 +71%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.93M +$239K +14,317 +8%
Deutsche Bank
37
Deutsche Bank
Germany
$2.79M +$2.65M +158,544 +730%
Two Sigma Investments
38
Two Sigma Investments
New York
$2.76M -$3M -179,847 -50%
IC
39
Ikarian Capital
Texas
$2.7M -$3.22M -192,609 -52%
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$2.62M +$2.82M +169,194 New
Squarepoint
41
Squarepoint
New York
$2.39M +$1.37M +81,859 +113%
Allspring Global Investments
42
Allspring Global Investments
North Carolina
$2.28M +$930K +55,684 +61%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$2.28M +$780K +46,694 +46%
Thrivent Financial for Lutherans
44
Thrivent Financial for Lutherans
Minnesota
$2.27M – – –
Citadel Advisors
45
Citadel Advisors
Florida
$2.26M +$813K +48,665 +50%
Barclays
46
Barclays
United Kingdom
$1.94M -$714K -42,770 -25%
CSS
47
Cubist Systematic Strategies
Connecticut
$1.91M -$195K -11,676 -9%
Ameriprise
48
Ameriprise
Minnesota
$1.77M -$95.9K -5,742 -5%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$1.76M +$1.45M +87,068 +326%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.74M +$265K +15,900 +16%
1
2
3 4 5

DCPH Hedge Fund Activity: Q1 2023 in Review

146 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q1 2023, worth a combined $897M — up 6.9% from $839M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DCPH positions and 22 closed out — a net gain of 3 holders — while 59 added to existing stakes and 41 trimmed.

The largest buyer was Deerfield Management, adding an estimated $47.9M. The largest seller was Wolverine Trading, exiting entirely with an estimated $28.7M sold.

  • 146 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q1 2023, up from 143 in Q4 2022.
  • Funds reported $897M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q1 2023, up 6.9% quarter-over-quarter.
  • 25 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q1 2023 and 22 closed out, a net change of +3 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q1 2023 was Deerfield Management, an estimated $47.9M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q1 2023 was Wolverine Trading, an estimated $28.7M sold.

Based on aggregated 13F filings for Q1 2023.